Dapsone
- Product NDC
- 67046-1477
- 11-digit product format
- 670461477
- Labeler code
- 67046
- Product ID
- 67046-1477_2d018cbb-21a4-5f63-e063-6394a90aadc3
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- dapsone
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Coupler LLC
- Application
- ANDA207165
- Marketing category
- ANDA
- Marketing start
- 2025-01-31
- Substance
- DAPSONE
- Active strength
- 100 mg/1
- Pharmacologic classes
- Sulfone [EPC], Sulfones [CS]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Related UNII Ingredients
| UNII | Preferred term | Registry number | Matched term |
|---|
| 8W5C518302 | DAPSONE | 80-08-0 | DAPSONE |
Packages
| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 67046-1477-3 | 67046147703 | 30 TABLET in 1 BLISTER PACK (67046-1477-3) | 30 tablet | 2025-01-31 | No | No | Historical |